123 related articles for article (PubMed ID: 24323690)
21. Preparation and properties of α-calcium sulphate hemihydrate and β-tricalcium phosphate bone substitute.
Mao K; Zhou F; Cui F; Li J; Hou X; Li P; Du M; Liang M; Wang Y
Biomed Mater Eng; 2013; 23(3):197-210. PubMed ID: 23629533
[TBL] [Abstract][Full Text] [Related]
22. Calcium sulfate- and calcium phosphate-based bone substitutes. Mimicry of the mineral phase of bone.
Tay BK; Patel VV; Bradford DS
Orthop Clin North Am; 1999 Oct; 30(4):615-23. PubMed ID: 10471766
[TBL] [Abstract][Full Text] [Related]
23. Intraosseous lipoma: a report of two cases with use of tricalcium phosphate bone void filler.
Japour C; Giorgini R; Aska G; Thomas M; Reynolds E
J Am Podiatr Med Assoc; 2010; 100(6):487-92. PubMed ID: 21084535
[TBL] [Abstract][Full Text] [Related]
24. Chronology of the radiographic appearances of the calcium sulphate-calcium phosphate synthetic bone graft composite following resection of bone tumours--a preliminary study of the normal post-operative appearances.
Kotnis NA; Parasu N; Finlay K; Jurriaans E; Ghert M
Skeletal Radiol; 2011 May; 40(5):563-70. PubMed ID: 20886210
[TBL] [Abstract][Full Text] [Related]
25. Nonallograft osteoconductive bone graft substitutes.
Bucholz RW
Clin Orthop Relat Res; 2002 Feb; (395):44-52. PubMed ID: 11937865
[TBL] [Abstract][Full Text] [Related]
26. Granular tricalcium phosphate grafting of cavitary lesions in human bone.
Nicholas RW; Lange TA
Clin Orthop Relat Res; 1994 Sep; (306):197-203. PubMed ID: 8070195
[TBL] [Abstract][Full Text] [Related]
27. Use of bone graft substitutes in the management of tibial plateau fractures.
Goff T; Kanakaris NK; Giannoudis PV
Injury; 2013 Jan; 44 Suppl 1():S86-94. PubMed ID: 23351879
[TBL] [Abstract][Full Text] [Related]
28. Orthopaedic applications of bone graft & graft substitutes: a review.
Nandi SK; Roy S; Mukherjee P; Kundu B; De DK; Basu D
Indian J Med Res; 2010 Jul; 132():15-30. PubMed ID: 20693585
[TBL] [Abstract][Full Text] [Related]
29. No negative effects of bone impaction grafting with bone and ceramic mixtures.
Arts JJ; Gardeniers JW; Welten ML; Verdonschot N; Schreurs BW; Buma P
Clin Orthop Relat Res; 2005 Sep; 438():239-47. PubMed ID: 16131897
[TBL] [Abstract][Full Text] [Related]
30. High failure rate after Beta-tricalcium phosphate grafting for the treatment of femoral head osteonecrosis: a retrospective analysis.
Liu P; Mu XH; Yu HC; Guan JL; Liu ZH; Wang WG; Zhang QD; Guo WS
BMC Musculoskelet Disord; 2020 Apr; 21(1):271. PubMed ID: 32340622
[TBL] [Abstract][Full Text] [Related]
31. [Comparative study of osteoplastic materials based on chitosan, alginate or fibrin with tricalcium phosphate].
Gurin AN; Komlev VS; Fedotov AIu; Berkovskiĭ AL; Mamonov VE; Grigor'ian AS
Stomatologiia (Mosk); 2014; 93(1):4-10. PubMed ID: 24576958
[TBL] [Abstract][Full Text] [Related]
32. Biological response to β-tricalcium phosphate/calcium sulfate synthetic graft material: an experimental study.
Leventis MD; Fairbairn P; Dontas I; Faratzis G; Valavanis KD; Khaldi L; Kostakis G; Eleftheriadis E
Implant Dent; 2014 Feb; 23(1):37-43. PubMed ID: 24384743
[TBL] [Abstract][Full Text] [Related]
33. The use of osteoconductive bone graft substitutes in orthopaedic trauma.
Hak DJ
J Am Acad Orthop Surg; 2007 Sep; 15(9):525-36. PubMed ID: 17761609
[TBL] [Abstract][Full Text] [Related]
34. A new β-tricalcium phosphate with uniform triple superporous structure as a filling material after curettage of bone tumor.
Seto S; Muramatsu K; Hashimoto T; Tominaga Y; Taguchi T
Anticancer Res; 2013 Nov; 33(11):5075-81. PubMed ID: 24222152
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of ultraporous β-tricalcium phosphate (vitoss) as bone graft substitute for cavitary defects in benign and low-grade malignant bone tumors.
Van Hoff C; Samora JB; Griesser MJ; Crist MK; Scharschmidt TJ; Mayerson JL
Am J Orthop (Belle Mead NJ); 2012 Jan; 41(1):20-3. PubMed ID: 22389890
[TBL] [Abstract][Full Text] [Related]
36. Anterior Cervical Discectomy and Fusion: Comparison of Fusion, Dysphagia, and Complication Rates Between Recombinant Human Bone Morphogenetic Protein-2 and Beta-Tricalcium Phosphate.
Lovasik BP; Holland CM; Howard BM; Baum GR; Rodts GE; Refai D
World Neurosurg; 2017 Jan; 97():674-683.e1. PubMed ID: 27989984
[TBL] [Abstract][Full Text] [Related]
37. A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate calcium phosphate or rh-BMP2.
Pimenta L; Marchi L; Oliveira L; Coutinho E; Amaral R
J Neurol Surg A Cent Eur Neurosurg; 2013 Nov; 74(6):343-50. PubMed ID: 23444134
[TBL] [Abstract][Full Text] [Related]
38. Clinical, radiological and histological study of the failure of cervical interbody fusions with bone substitutes.
Xie Y; Chopin D; Hardouin P; Lu J
Eur Spine J; 2006 Aug; 15(8):1196-203. PubMed ID: 16429285
[TBL] [Abstract][Full Text] [Related]
39. Increased bone formation using calcium sulfate-calcium phosphate composite graft.
Urban RM; Turner TM; Hall DJ; Inoue N; Gitelis S
Clin Orthop Relat Res; 2007 Jun; 459():110-7. PubMed ID: 17415007
[TBL] [Abstract][Full Text] [Related]
40. [Letters to the editor].
Orv Hetil; 2008 Aug; 149(32):1525. PubMed ID: 18672445
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
